Fujisawa, Tomoyuki
Hamamatsu University School of Medicine
3 papers on CoChatORCID 0000-0002-8809-1781
Most cited papers
- Verified
Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer
Karayama, M., Masuda, J., Mori, K., Yasui, H., Hozumi, H., Suzuki, Y., Furuhashi, K., Fujisawa, T., Enomoto, N., Nakamura, Y., et al. (2021) · Clinical and Translational Oncology
Cancer Immunotherapy and BiomarkersTryptophan and brain disorders
Cited by 84
- Verified
LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis
Enomoto, Y., Matsushima, S., Shibata, K., Aoshima, Y., Yagi, H., Meguro, S., Kawasaki, H., Kosugi, I., Fujisawa, T., Enomoto, N., et al. (2018) · Clinical Science
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and Treatments
Cited by 60
- Verified
The prognostic significance of pneumothorax in patients with idiopathic pulmonary fibrosis
Nishimoto, K., Fujisawa, T., Yoshimura, K., Enomoto, Y., Enomoto, N., Nakamura, Y., Inui, N., Sumikawa, H., Johkoh, T., Colby, T. V., et al. (2018) · Respirology
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPleural and Pulmonary Diseases
Cited by 47
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free